Sign In
Buy ENZ
$0.314
+0 (+0%)
At Close: Aug 01, 2025
Dr. Elazar Rabbani to remain Chairperson of the Board and will assume new role as Chief Scientific Officer
Enzo Biochem, Inc. (ENZ) Management on Q4 2021 Results - Earnings Call Transcript
12:28pm, Tuesday, 12'th Oct 2021
Enzo Biochem, Inc. (ENZ) Management on Q4 2021 Results - Earnings Call Transcript
Enzo Biochem Clocks 27% Revenue Growth In Q4, Margin Remains Stable
09:22am, Tuesday, 12'th Oct 2021
Biosciences and diagnostics company Enzo Biochem Inc (NYSE: ENZ) reported fourth-quarter FY21 revenue growth of 27% year-on-year to $24.8 million. Revenue decreased 24% sequentially.
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
07:00am, Tuesday, 12'th Oct 2021
Conference call and live webcast scheduled for today, Tuesday, October 12, 2021 at 8:30 am (ET)
ENZ Stock Increases Over 9% Pre-Market: Why It Happened
09:10am, Tuesday, 20'th Jul 2021
The stock price of Enzo Biochem, Inc. (NYSE: ENZ) increased by over 9% pre-market. This is why it happened.
Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel
12:00pm, Tuesday, 15'th Jun 2021
Testing will be available through CLX Health's TrustAssure™ Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to tr
Enzo Biochem, Inc. (ENZ) Q3 2021 Results - Earnings Call Transcript
09:47pm, Wednesday, 09'th Jun 2021
Enzo Biochem, Inc. (ENZ) Q3 2021 Results - Earnings Call Transcript
Enzo Biochem Reports Third Quarter Fiscal 2021 Results
04:05pm, Wednesday, 09'th Jun 2021
Conference call and live webcast scheduled for today, Wednesday, June 9, 2021 at 4:30 PM (ET).
Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9
04:05pm, Tuesday, 01'st Jun 2021
Conference Call and Webcast Scheduled for June 9, 2021, 4:30 pm ET Conference Call and Webcast Scheduled for June 9, 2021, 4:30 pm ET
ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM
04:15pm, Wednesday, 17'th Mar 2021
NEW YORK, NY, March 17, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital Marke
ENZ Stock Price Increases Over 30% Pre-Market: Why It Happened
05:45am, Tuesday, 16'th Mar 2021
The stock price of Enzo Biochem, Inc. (NYSE: ENZ) increased by over 30% pre-market. This is why it happened.
Enzo Biochem, Inc. (ENZ) Q2 2021 Results - Earnings Call Transcript
10:17pm, Monday, 15'th Mar 2021
Enzo Biochem, Inc. (ENZ) Q2 2021 Results - Earnings Call Transcript
Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates
04:05pm, Monday, 15'th Mar 2021
Conference call and live webcast scheduled for today, Monday, March 15, 2021 at 4:30 pm (ET)
Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15
04:05pm, Monday, 01'st Mar 2021
Conference Call and Webcast Scheduled for March 15, 2021, 4:30 pm ET Conference Call and Webcast Scheduled for March 15, 2021, 4:30 pm ET
Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
08:30am, Wednesday, 03'rd Feb 2021
NEW YORK, NY, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the recent issuance of U
